The story of olaparib: a life-saving cancer drug 

The drug olaparib has now been used to treat over 140,000 patients globally, changing the outlook for people with breast, ovarian, prostate and pancreatic cancers. Professor Sir Steve Jackson talks about chance, risk, curiosity and shots-on-goal in the journey of his discovery.
Find out more here: www.cam.ac.uk/...